In more than 10 years of activity as the Clinical Pharmacology and Discovery Medicine department of the Neuroscience Centre of Excellence in Drug Discovery at GlaxoSmithKline the Physicians and Scientists that form the Clinical Sciences group have taken more than 20 NCEs into humans, have designed and conducted 15 Phase II clinical studies 8 of which reached PoC and have designed and conducted more than 100 Clinical Pharmacology and Experimental Medicine studies with particular use of Imaging and biomarkers. In addition our pharmacometric expertise has always been at the forefront of innovation in particular for the implementation of clinical trial adaptive designs, modelling and simulation.
Aptuit Clinical Sciences can provide a series of integrated and/or stand-alone activities according to the most recent ICH/GCP, EMEA & FDA requirements, including: